Armata Pharmaceuticals (ARMP) Return on Sales [ROS] (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted Return on Sales [ROS] of -14806.45% for Q2 2020.
Powered by 
Analysis
Armata Pharmaceuticals (ARMP) Return on Sales [ROS] (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2020, Return on Sales [ROS] at Armata Pharmaceuticals was -17661.54%; for FY2017, it came in at -14048.70%, down 5057.16 percentage points from FY2016.
- Annual Return on Sales [ROS] shows a four-year change of +1240.19 percentage points (FY2013 to FY2017).
- In prior years, Armata Pharmaceuticals' Return on Sales [ROS] was -8991.54% in FY2016 (-6838.49 pp), -2153.05% in FY2015 (+1296.83 pp), -3449.88% in FY2014 (+11839.01 pp) and -15288.89% in FY2013.
- The Q2 2020 figure stands as the highest quarterly Return on Sales [ROS] since Q4 2017.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2017, with a gain of 42102.27 percentage points; the weakest was Q4 2016, with a drop of 51630.40 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Armata Pharmaceuticals | 137.07 Mn | 84.78 Mn | - | -410.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -410.84% |
| Mar 31, 2026 | -1,113.43% |
| Dec 31, 2025 | -1,274.01% |
| Sep 30, 2025 | -670.92% |
| Jun 30, 2025 | -315.54% |
| Mar 31, 2025 | -1,668.23% |
| Dec 31, 2024 | -853.36% |
| Sep 30, 2024 | -328.15% |
| Mar 31, 2024 | -1,058.80% |
| Jun 30, 2020 | -14,806.45% |
| Dec 31, 2017 | -11,825.00% |
| Sep 30, 2017 | -1,963.16% |
| Jun 30, 2017 | -34,592.86% |
| Mar 31, 2017 | -11,582.76% |
| Dec 31, 2016 | -53,927.27% |
| Sep 30, 2016 | -11,748.28% |
| Jun 30, 2016 | -3,484.47% |
| Mar 31, 2016 | -4,262.26% |
| Dec 31, 2015 | -2,296.88% |
| Sep 30, 2015 | -1,697.90% |
API Access
Armata Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ARMP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ARMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ARMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();